Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 13/20 | 0.48 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.33 |
| ▸ | PYGL | P06737 | 2/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | PYGM | P11217 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7407650 | 0.86 | F10 (0.44) | F10CYP51A1PYGLSLC2A1PYGM | |
| SCHEMBL7412784 | 0.84 | F10 (0.52) | F10SLC2A1IDH1NR4A2SOS2 | |
| SCHEMBL7412788 | 0.84 | F10 (0.52) | F10SLC2A1IDH1NR4A2SOS2 | |
| Trifluoroacetic Acid SCHEMBL7537550 | 0.79 | F10 (0.47) | F10CYP51A1PYGLSLC2A1PYGM | |
| Trifluoroacetic Acid SCHEMBL7407257 | 0.79 | F10 (0.47) | F10CYP51A1PYGLSLC2A1PYGM | |
| SCHEMBL1651767 | 0.76 | F10 (0.79) | F10NR4A2SOS2 | |
| SCHEMBL1654359 | 0.75 | F10 (0.57) | F10SLC2A1NR4A2SOS2 | |
| SCHEMBL1652551 | 0.75 | F10 (0.57) | F10SLC2A1NR4A2SOS2 | |
| SCHEMBL7543827 | 0.74 | F10 (0.47) | F10F2 | |
| SCHEMBL7371873 | 0.74 | F10 (0.48) | F10CYP51A1PYGLSLC2A1NR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020013310-A1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2002-01-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013310-A1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | STS, ARSA, F12 | F10 20/4885CYP51A1 181/4885PYGL 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.